Claire Wainwright

12PUBLICATIONS
42CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyCarbon capture engineering (excl. sequestration)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis.

|Sep 08, 2025
Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study.

Pedro Miranda Afonso, Grace C Zhou, Weiji Su

|Aug 22, 2025
Hitting the Sweet Spot: The Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis.

Tonia A Douglas, Sarah K McMahon, Claire E Wainwright

|Apr 10, 2025
Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study.

Marcus A Mall, Claire E Wainwright, Julian Legg

|Feb 04, 2025
SHIFTing goals in cystic fibrosis-managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium.

Jonathan E M O'Donnell, Lucy A Hastings, Julie N Briody

|Apr 27, 2023
Airway inflammation and lung function in cystic fibrosis.

Claire E Wainwright

Pageof 2

Frequent Collaborators

2 joint publications

Marcus A Mall

2 joint publications

Tonia A Douglas

2 joint publications

Scott Cameron Bell

1 joint publications

Matthew D Wong